Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
CARE RatingsBOM:534804 +1.00%81 Shareholder Yield % is 1.06% as of Mar. 2026, which is 52% below its 10-year median of 2.23. GuruFocus rates BOM:534804 with a GF Score™ of 81/100 and a GF Value™ of ₹1,709.93 (Fairly Valued). The stock has 2 warning signs investors should review. Among 711 Capital Markets companies, CARE Ratings ranks better than 62.17% on this metric.
Shareholder Yield % is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. It is a measure of shareholder return.
As of today, CARE Ratings's Shareholder Yield % was 1.06%.
CARE Ratings (BOM:534804) Shareholder Yield % Explanation
Shareholder Yield % is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. The term was coined by William W. Priest of Epoch Investment Partners in a paper in 2005 entitled The Case for Shareholder Yield as a Dominant Driver of Future Equity Returns. William Priest indicated that "shareholder yield is a term that we came up with to reflect the various ways dividends can be paid to owners of a business in a publicly-traded company."
Dividend Yield % shows how much a company pays out in dividends each year relative to its stock price, which is most obvious form of shareholder return.
Buyback Yield % is the net repurchase of shares outstanding over the market capital of the company. Shares repurchases also increase shareholder value by returning the money back to shareholders.
Net Debt Paydown Yield % is the change in average of four quarters of company's total debt over a company's market cap. Assuming the total value of a company remains that same, shareholder value is increased as debt is reduced.
CARE Ratings Shareholder Yield % Related Terms
CARE Ratings Shareholder Yield % Historical Data
* Premium members only.
The historical data trend for CARE Ratings's Shareholder Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:534804 vs SPGI, CME, ICE: Shareholder Yield % Comparison
For the Financial Data & Stock Exchanges subindustry, CARE Ratings's Shareholder Yield %, along with its competitors' market caps and Shareholder Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
CARE Ratings Shareholder Yield % vs Capital Markets Industry
For the Capital Markets industry and Financial Services sector, CARE Ratings's Shareholder Yield % distribution charts can be found below:
* The bar in red indicates where CARE Ratings's Shareholder Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* All the data are calculated by TTM values. Note that if a companies is traded in several exchanges, then we calculate the company level data for Shareholder Yield % using the primary share class stock data. The calculation result in definition page is for demonstration purpose only, and it's showing the share class level data. Therefore, the numbers in the calculation may differ from elsewhere if the stock is not a primary share.
CARE Ratings (BOM:534804) has a Shareholder Yield % of 1.06% as of Mar. 2026. Shareholder Yield is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. View historical data on CARE Ratings and its competitors. This is 52% below median its historical median of 2.23. Over the past decade, CARE Ratings' Shareholder Yield % has ranged from 0.79 to 8.86. According to the industry distribution chart, CARE Ratings ranks #269 out of 711 companies in the Capital Markets industry, placing it in the top 37.8%.
Is CARE Ratings' Shareholder Yield % too high?
CARE Ratings' current Shareholder Yield % of 1.06% is 52% below median its 10-year median of 2.23. Over the past 10 years, this metric has ranged from a low of 0.79 to a high of 8.86. Based on the distribution chart, CARE Ratings ranks #269 out of 711 companies in the Capital Markets industry, which is above the industry midpoint. Overall, CARE Ratings has a GF Score™ of 81/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does CARE Ratings' Shareholder Yield % compare to SPGI and CME?
According to the Capital Markets industry distribution chart, CARE Ratings ranks #269 out of 711 companies for Shareholder Yield %. This puts CARE Ratings in the upper half of its industry. Historically, CARE Ratings' own Shareholder Yield % has ranged from 0.79 to 8.86 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Shareholder Yield % for a Capital Markets company?
A good Shareholder Yield % depends on the Capital Markets industry context. However, Shareholder Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Shareholder Yield % mean?
A high Shareholder Yield % can signal that a stock is expensive relative to its fundamentals. Shareholder Yield is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. View historical data on CARE Ratings and its competitors. CARE Ratings's current Shareholder Yield % is 1.06%, which is 52% below median its own 10-year median of 2.23. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CARE Ratings stock overvalued right now?
Based on GuruFocus' analysis, CARE Ratings (BOM:534804) is currently considered Fairly Valued. The stock's GF Value™ is ₹1,709.93, compared to a current price of ₹1,746.10 — trading 2.1% above its estimated fair value. The current Shareholder Yield % is 1.06%, which is 52% below median its 10-year median of 2.23. CARE Ratings' overall GF Score™ is 81/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Shareholder Yield % calculated?
Shareholder Yield % is calculated from a company's financial statements. For CARE Ratings (BOM:534804), the current Shareholder Yield % is 1.06% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is CARE Ratings (BOM:534804) Overvalued in 2026?
Based on GuruFocus' analysis, CARE Ratings stock appears to be overvalued.
The current stock price of ₹1,746.10 is trading 2.1% above its estimated GF Value™ of ₹1,709.93.
GuruFocus considers CARE Ratings to be Fairly Valued.
Key valuation signals for BOM:534804:
Shareholder Yield %: 1.06% (52% below median its 10-year median of 2.23)
GF Value™: ₹1,709.93 vs. price of ₹1,746.10 (2.1% above fair value)
No single metric tells the full story. See the BOM:534804 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
CARE Ratings Ltd provides various credit ratings that helps corporates to raise capital for their various requirements and assists the investors to form an informed investment decision based on the credit risk and their own risk-return expectations. The company works in Bank Loan Ratings; Capital Market Instruments, Including NCDs/ Bonds/ Hybrids/ CPs/CDs, etc; Structured Finance Ratings; Monitoring Agency Services for Equity Capital; Rating of REITs /InvITs; Resolution Plan Ratings; Recovery Ratings; Issuer Ratings. The company's segment includes Ratings and related services; and Others. The company generates majority of revenue from Ratings and related services. The company has presence in India, and Outside India. It generates majority of revenue from India.
81GF Score
Get the complete analysis for BOM:534804
Shareholder Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:534804 has been successfully added to your 
